4.2.4Consolidated Statement of Changes in Equity
in millions of US$  | Notes  | Issued share capital  | Share premium reserve  | Treasury shares  | Retained earnings  | Other reserves  | Attributable to shareholders  | Non-controlling interests  | Total Equity  | 
|---|---|---|---|---|---|---|---|---|---|
At 1 January 2024  | 50  | 1,007  | (26)  | 2,478  | 224  | 3,733  | 1,797  | 5,531  | |
Profit/(loss) for the period  | -  | -  | -  | 150  | -  | 150  | 61  | 211  | |
Foreign currency translation  | (3)  | -  | 2  | 0  | 34  | 33  | 2  | 35  | |
Remeasurements of defined benefit provisions  | -  | -  | -  | -  | 0  | 0  | -  | 0  | |
Cash flow hedges  | -  | -  | -  | -  | (153)  | (153)  | 57  | (96)  | |
Deferred tax on cash flow hedges  | -  | -  | -  | -  | 22  | 22  | (8)  | 14  | |
Total comprehensive income for the period  | (3)  | -  | 2  | 150  | (97)  | 52  | 111  | 163  | |
IFRS 2 vesting cost of share-based payments  | -  | -  | -  | -  | 21  | 21  | -  | 21  | |
Re-issuance treasury shares on the share-based scheme  | (0)  | -  | 25  | 0  | (19)  | 5  | -  | 5  | |
Purchase of treasury shares  | -  | -  | (102)  | -  | -  | (102)  | -  | (102)  | |
Share cancellation  | (1)  | -  | 70  | (69)  | -  | 0  | -  | 0  | |
Cash dividend  | -  | -  | -  | (150)  | -  | (150)  | (99)  | (249)  | |
Acquisition of subsidiaries  | -  | -  | -  | -  | -  | -  | 178  | 178  | |
Transaction with non-controlling interests  | -  | -  | -  | 82  | (21)  | 61  | 238  | 299  | |
At 31 December 2024  | 46  | 1,007  | (31)  | 2,489  | 108  | 3,619  | 2,225  | 5,844  | 
in millions of US$  | Notes  | Issued share capital  | Share premium reserve  | Treasury shares  | Retained earnings  | Other reserves  | Attributable to shareholders  | Non-controlling interests  | Total Equity  | 
|---|---|---|---|---|---|---|---|---|---|
At 1 January 2023  | 48  | 1,007  | (42)  | 2,179  | 204  | 3,397  | 1,517  | 4,914  | |
Profit/(loss) for the period  | -  | -  | -  | 491  | -  | 491  | 123  | 614  | |
Foreign currency translation  | 2  | -  | (1)  | -  | (2)  | (1)  | (1)  | (2)  | |
Remeasurements of defined benefit provisions  | -  | -  | -  | -  | (4)  | (4)  | -  | (4)  | |
Cash flow hedges  | -  | -  | -  | -  | 68  | 68  | (5)  | 62  | |
Deferred tax on cash flow hedges  | -  | -  | -  | -  | (45)  | (45)  | (12)  | (57)  | |
Total comprehensive income for the period  | 2  | -  | (1)  | 491  | 17  | 509  | 106  | 615  | |
IFRS 2 vesting cost of share-based payments  | -  | -  | -  | -  | 20  | 20  | -  | 20  | |
Re-issuance treasury shares on the share-based scheme  | -  | -  | 21  | (2)  | (16)  | 4  | -  | 4  | |
Purchase of treasury shares  | -  | -  | (5)  | -  | -  | (5)  | -  | (5)  | |
Cash dividend  | -  | -  | -  | (197)  | -  | (197)  | (81)  | (278)  | |
Transaction with non-controlling interests  | -  | -  | -  | 6  | -  | 6  | 255  | 261  | |
At 31 December 2023  | 50  | 1,007  | (26)  | 2,478  | 224  | 3,733  | 1,797  | 5,531  |